Mats Uno Olsson
Director/Miembro de la Junta en RespiVert Ltd. .
Origen de la red de primer grado Mats Uno Olsson.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
RespiVert Ltd.
 RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom.
2
| Subsidiary | Medical Distributors | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Mats Uno Olsson a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| VERNALIS | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Trinity College, Cambridge | College/University | Doctorate Degree | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
Johnson & Johnson Innovation Ltd.
 Johnson & Johnson Innovation Ltd. Investment ManagersFinance Johnson & Johnson Innovation Ltd is a private equity subsidiary of Johnson & Johnson Innovation - JJDC, Inc. founded in 2000. The firm is headquartered in Buckinghamshire, United Kingdom. | Investment Managers | Director/Board Member | |
XO1 Ltd.
 XO1 Ltd. Medical/Nursing ServicesHealth Services XO1 Ltd. develops a novel anticoagulant drug. The firm operates as a biopharmaceutical company. The company was founded by David J. Grainger on February 28, 2013 and is headquartered in High Wycombe, the United Kingdom. | Medical/Nursing Services | Director/Board Member |
Estadísticas
Internacional
| Reino Unido | 5 |
Sectorial
| Health Technology | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
| Finance | 2 |
| Health Services | 2 |
Operativa
| Director/Board Member | 5 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Nerida Scott | 6 |
| Ian Keith Anderson | 1 |
- Bolsa de valores
- Insiders
- Mats Uno Olsson
- Conexiones Empresas
